M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Keryx Biopharmaceuticals Inc issues common shares to public at USD14.50 per share
Pharmaceutical company Keryx Biopharmaceuticals Inc (NasdaqCM:KERX) revealed on Wednesday that it has priced a public offering of 6,900,000 common shares at USD14.50 per share.
The company has provided the underwriters with a 30-day option to purchase additional common shares that is equal...
If you want to view the full text, you must first purchase archive credits.
Return to Archives